Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD

:::

Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD

發稿日期: 2023-06-02 發稿單位: 創服育成中心

GeneOnline is honored to have Prof. Brian A. Van Tine, MD, PhD for an interview. As a medical oncologist with research expertise in metabolic deficiencies in sarcoma and amino acid deprivation therapies, Dr. Van Tine is currently a Professor of Medicine of the Division of Medical Oncology at Washington University in St. Louis. During the interview, he used ADI-PEG 20 as an example to explain how amino acid deprivation therapies could help to fight cancer cells and the clinical application of ADI-PEG 20 in treating soft tissue sarcoma.